Skip to main content
. 2022 May 21;129(2):182–188.e1. doi: 10.1016/j.anai.2022.05.014

Figure 1.

Figure 1

Flowchart of patients recruited and exclusion criteria. Most of the patients reported an allergic reaction to more than 1 agent. AZ, AstraZeneca; COVID-19, coronavirus disease 2019; GD, graded dosing; MUHC, McGill University Health Centre; PEG, polyethylene glycol; PS, polysorbate; SPT, skin prick test.